Navigation Links
Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
Date:4/2/2009

b>About Cethromycin

In November 2008, the FDA filed the Company's NDA for cethromycin and established a target Prescription Drug User Fee Act (PDUFA) action date for the cethromycin NDA of July 31, 2009. Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria, certain Gram-negative bacteria and atypical organisms associated with respiratory tract infections. In in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin is also being investigated as a broad spectrum biodefense countermeasure to combat agents of bioterror including anthrax, tularemia, plague and melioidosis. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer, respiratory diseases and biodefense. For more information, please visit us on the web at www.advancedlifesciences.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development,
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
3. Advanced Age No Bar to Liver Transplant
4. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
5. Advanced technologies aim to transform the coaching of top athletes
6. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
7. Advanced Life Sciences Joins NASDAQ Capital Market
8. Experimental drug shows promise in advanced kidney cancer
9. TCS Healthcare Technologies Announces Full Integration of Case Management Adherence Guidelines into Acuity Advanced Care(TM) System
10. OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... FRANCISCO, CA (PRWEB) , ... September 03, 2015 ... ... transforming the real estate investment landscape by connecting accredited and institutional investors to ... mezzanine financing products designed to meet demand from both investors and sponsoring ...
(Date:9/3/2015)... , ... September 03, 2015 , ... The Linda ... control, the surface of a comet, the IceCube observatory at the South Pole, and ... , The Fall Lecture Series for the world's foremost independently funded research library ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Dr. Robert ... of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical Center, effective July ... Winchell is a nationally renowned expert in care for the critically injured and the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Atlantic Information Services, Inc. ... Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” In this Sept. 16 program, ... will discuss how plan sponsors are adopting bold, innovative strategies to control soaring ...
(Date:9/3/2015)... ... September 03, 2015 , ... ProScrub is a set of automated tools that ... and custom speed effects without the use of keyframes. Utilize ProScrub's powerful sliders ... tools are perfect complements to energetic video productions. ProScrub is a Final ...
Breaking Medicine News(10 mins):Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Oct. ... outbreak first linked to tainted cantaloupes has risen to 25, ... 26 states, the U.S. Centers for Disease Control and Prevention ... the cantaloupes in question were recalled in mid-September, more cases ...
... as immunotherapies and targeted therapies that specifically target signaling ... in 20%-50% of cancer patients taking them, which can ... study published Oct. 18 in the Journal ... past two decades, novel antineoplastic agents have been introduced ...
... PROVIDENCE, R.I. [Brown University] A study published online Oct. ... provides some new but qualified support for the idea ... risk of developing deadly brain tumors. People with somewhat ... out the body,s immune response to allergens, were significantly less ...
... LeFevre, MD, Future of Family Medicine Professor and vice ... of Missouri, has been elected to the Institute of ... is considered one of the highest honors in the ... have demonstrated outstanding professional achievement and commitment to service. ...
... & White Healthcare in Temple is one of three sites ... doctoral psychology students that will help alleviate mental health workforce ... a five-year $638,853 grant from the Hogg Foundation for Mental ... will fund a new internship program that will enable students ...
... results from a large-scale Phase III trial of RTS,S*, published ... (NEJM), show the malaria vaccine candidate to provide young ... with an acceptable safety and tolerability profile. The results were ... & Melinda Gates Foundation in Seattle, Washington. Half the ...
Cached Medicine News:Health News:25 Deaths Now Blamed on Cantaloupe-Linked Listeria Outbreak 2Health News:Antineoplastic agents associated with thyroid dysfunction 2Health News:More evidence that allergies may help in fighting brain tumors 2Health News:Family and community medicine leader elected to Institute of Medicine 2Health News:Scott & White Healthcare is 1 of 3 in Texas to receive workforce development grants 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 3
(Date:9/3/2015)... 3, 2015 The report "Biocides ... acids, Phenolics, and Others) and by Application (Water treatment, ... coatings, and Others) - Global Trends and Forecasts to ... Market with an analysis and forecast for types and ... Browse   88 tables and   63 figures ...
(Date:9/2/2015)... 2, 2015 About Balloon ... one or more vertebral bodies, resulting in persistent ... bone disease, is a leading cause of VCF ... metastatic spinal tumors, and traumatic injuries also cause ... kyphoplasty to rectify the condition. Both procedures are ...
(Date:9/2/2015)... , Sept. 2, 2015  The report on ... market of breast cancer drugs on the basis of ... usually originates from the inner lining of milk ducts ... a malignant type of tumor that can spread to ... cancer which starts in lobules is referred as lobular ...
Breaking Medicine Technology:Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5Global Balloon Kyphoplasty Market 2015-2019 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3
...  "This is a significant decision in a case being ... entire pharmaceutical industry," commented Benjamin H. Anderson, Esq. "We ... hearing was not necessary and that the three-judge panel ... the diet drug Redux (commonly known as fen-phen) should ...
... EntreMed, Inc. (Nasdaq: ENMD ), a ... of cancer, today announced that it has received ... that it has regained compliance with the minimum ... requirement for continued listing on the NASDAQ Capital ...
Cached Medicine Technology:EntreMed Receives Notice of NASDAQ Compliance 2
... Addressing the key clinical and economic issues ... System is designed to maximize tension control ... The system combines efficient instrumentation with a ... Grip system is indicated for general orthopaedic ...
... The Minimally Invasive Hip Instruments ... THA through a mini-incision using ... set of instruments helps reduce ... invasive THA by optimizing exposure ...
... The Inteq TFCC ... facilitates suturing of the ... the dorsal capsule when ... The Inteq system should ...
... Series I Small Joint ... features a complete line ... instruments specifically designed for ... are available in a ...
Medicine Products: